{"content":"<li class=\"n-box-item date-title\" data-end=\"1514523599\" data-start=\"1514437200\" data-txt=\"Monday, December 23, 2019\">Thursday, December 28, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3320374\" data-ts=\"1514500394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320374-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='green'>+4.2%</font>. <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a>&nbsp;<font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a>&nbsp;<font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a>&nbsp;<font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>&nbsp;<font color='green'>+1.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320374\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$TXMD $QIWI $HL - After Hours Gainers / Losers https://seekingalpha.com/news/3320374-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3320374-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320366\" data-ts=\"1514497199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320366-therapeuticsmd-submits-nda-for-txminus-001hr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD submits NDA for TX-001HR</a></h4><ul><li>        TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) <a href=\"https://seekingalpha.com/pr/17034931-therapeuticsmd-announces-submission-new-drug-application-txminus-001hr\" target=\"_blank\">announces</a> submitting a New Drug Application for TX-001HR for moderate-to-severe vasomotor symptoms due to menopause.</li><li>               The NDA is supported with the Phase 3 Replenish trial. &nbsp;&nbsp;</li><li>               TherapeuticsMD shares are&nbsp;<font color='green'>up 5.4%</font>&nbsp;aftermarket.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320366\" data-linked=\"TherapeuticsMD submits NDA for TX-001HR\" data-tweet=\"$TXMD - TherapeuticsMD submits NDA for TX-001HR https://seekingalpha.com/news/3320366-therapeuticsmd-submits-nda-for-txminus-001hr?source=tweet\" data-url=\"https://seekingalpha.com/news/3320366-therapeuticsmd-submits-nda-for-txminus-001hr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320362\" data-ts=\"1514494840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPLO\" target=\"_blank\">DPLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320362-fda-finds-issues-diplomat-pharmacy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA finds issues at Diplomat Pharmacy</a></h4><ul><li>The FDA today <a href=\"https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm590759.pdf\" target=\"_blank\">published a Form 483 letter</a> of objectionable observations from an inspection of Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>).</li><li>Among the findings were the release of drugs of incorrect strengths and non-sterile areas.</li><li>DPLO initially dove lower on the release, but has returned to its previous level,&nbsp;<font color='green'>up 0.25%</font>&nbsp;on the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320362\" data-linked=\"FDA finds issues at Diplomat Pharmacy\" data-tweet=\"$DPLO - FDA finds issues at Diplomat Pharmacy https://seekingalpha.com/news/3320362-fda-finds-issues-diplomat-pharmacy?source=tweet\" data-url=\"https://seekingalpha.com/news/3320362-fda-finds-issues-diplomat-pharmacy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320361\" data-ts=\"1514493706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPLR\" target=\"_blank\">XPLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320361-xplore-technologies-updates-insider-buying-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xplore Technologies updates insider buying, full-year guidance</a></h4><ul><li>Xplore Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/XPLR' title='Xplore Technologies Corp.'>XPLR</a>) updates on recent insider buying following November&rsquo;s CEO transition and reiterates its full-year outlook.</li><li>Multiple executives purchased 42,800 shares at an average price of $3.10 per share from November 14 to December 8. The execs include acting CEO Tom Wilkinson, VP of Marketing John Graff, and VP of Sales for Enterprise and the Americas Randy Denny.</li><li>Full-year outlook has revenue from $75M to $85M with gross margin from 28% to 30% and operating expenses between $23M and $25M.</li><li>Xplore shares are&nbsp;<font color='red'>down 1.1%</font>.</li><li>Correction: Corrected typo listing the purchases as sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320361\" data-linked=\"Xplore Technologies updates insider buying, full-year guidance\" data-tweet=\"$XPLR - Xplore Technologies updates insider buying, full-year guidance https://seekingalpha.com/news/3320361-xplore-technologies-updates-insider-buying-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3320361-xplore-technologies-updates-insider-buying-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320358\" data-ts=\"1514492255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNWV\" target=\"_blank\">SNWV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320358-sanuwaveplus-73-on-fda-marketing-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanuwave +73% on FDA marketing approval</a></h4><ul><li>        The FDA <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm590784.htm\" target=\"_blank\">permits marketing</a> of Sanuwave&rsquo;s (<a href='https://seekingalpha.com/symbol/SNWV' title='SANUWAVE Health, Inc.'>OTCQB:SNWV</a>) Dermapace System, a shock wave device to treat diabetic foot ulcers. &nbsp;</li><li>        The CDC estimates that 30.3M people in the U.S. have been diagnosed with diabetes and about 25% will experience a foot ulcer at some point. Amputation can become necessary when poor circulation prevents the ulcer from healing. &nbsp;</li><li>        Sanuwave shares are&nbsp;<font color='green'>up 73%</font>&nbsp;to $0.25.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320358\" data-linked=\"Sanuwave +73% on FDA marketing approval\" data-tweet=\"$SNWV - Sanuwave +73% on FDA marketing approval https://seekingalpha.com/news/3320358-sanuwaveplus-73-on-fda-marketing-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3320358-sanuwaveplus-73-on-fda-marketing-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320353\" data-ts=\"1514487851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LINU-OLD\" target=\"_blank\">LINU-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320353-liniu-technology-soars-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LiNiu Technology soars after earnings</a></h4><ul> <li>LiNiu Technology Group (NASDAQ:<a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a>) is <font color='green'>up 120%</font> after posting results for the first half of the fiscal year.</li> <li>Due to the closing of VIP gaming operations by the company, revenue fell from $28.5M to $1.45M amid a corporate reset.</li> <li>\"During the first half of 2017, we concentrated on launching the LiNiu Network and creating awareness for agricultural customers and suppliers to utilize our new platform,\" notes LiNiu co-CEO Wang Shun Yang.</li> <li>\"As we move into 2018, we plan to further ramp up our efforts to drive customer awareness and traffic by establishing new relationships with larger online platforms.\" he adds.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320299-liniu-technology-reports-1h-results\" target=\"_blank\">LiNiu Technology reports 1H results</a> (Dec. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320353\" data-linked=\"LiNiu Technology soars after earnings\" data-tweet=\"$LINU-OLD - LiNiu Technology soars after earnings https://seekingalpha.com/news/3320353-liniu-technology-soars-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3320353-liniu-technology-soars-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320352\" data-ts=\"1514486662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320352-guggenheim-sees-10-upside-for-sonic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guggenheim sees 10% upside for Sonic</a></h4><ul> <li>Guggenheim Partners backs ups its bullish view on Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='red'>-0.5%</font>) in a fresh note to clients.</li> <li>The investment firm keeps a Buy rating and lifts its price target to <a href=\"https://twitter.com/RatingsNetwork/status/946407234774413312\" target=\"_blank\">$31</a> to rep 10% upside potential for the restaurant stock.</li> <li>Sonic has traded between $22.11 and $30.05 over the last 52 weeks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320169-next-sizzling-pace-restaurant-m\" target=\"_blank\">What next after sizzling pace of restaurant M&amp;A?</a> (Dec. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320352\" data-linked=\"Guggenheim sees 10% upside for Sonic\" data-tweet=\"$SONC - Guggenheim sees 10% upside for Sonic https://seekingalpha.com/news/3320352-guggenheim-sees-10-upside-for-sonic?source=tweet\" data-url=\"https://seekingalpha.com/news/3320352-guggenheim-sees-10-upside-for-sonic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320351\" data-ts=\"1514485030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320351-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='green'>+105%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+79%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+28%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+21%</font>.<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/YECO-OLD' title='Yulong Eco-Materials'>YECO-OLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+14%</font>. <b> </b></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AMCN' title='AirMedia Group Inc'>AMCN</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320351\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$LINU-OLD $LIVE $VTVT - Midday Gainers / Losers https://seekingalpha.com/news/3320351-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3320351-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320349\" data-ts=\"1514484682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320349-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AMBC' title='Ambac Financial'>AMBC</a> <font color='green'>+7%</font>.<a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='green'>+6%</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FSAM' title='Fifth Street Asset Management Inc.A'>OTCPK:FSAM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MARPS' title='Marine Petroleum Trust'>MARPS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320349\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GCAP $AMBC $NHLD - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3320349-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320349-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320347\" data-ts=\"1514483951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320347-vtv-therapeuticsplus-36_3-on-insider-buying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VTv Therapeutics +36.3% on insider buying</a></h4><ul><li>        VTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>) director Ronald O. Perelman discloses acquiring 50K shares for $4.0344 or about $201.7K</li><li>        The shares bring Perelman&rsquo;s stake up to 27%.</li><li>                  VTv shares are&nbsp;<font color='green'>up 36.3%</font>. &nbsp;   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320347\" data-linked=\"VTv Therapeutics +36.3% on insider buying\" data-tweet=\"$VTVT - VTv Therapeutics +36.3% on insider buying https://seekingalpha.com/news/3320347-vtv-therapeuticsplus-36_3-on-insider-buying?source=tweet\" data-url=\"https://seekingalpha.com/news/3320347-vtv-therapeuticsplus-36_3-on-insider-buying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320342\" data-ts=\"1514481678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLD\" target=\"_blank\">RGLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320342-royal-gold-down-nearly-7-on-mine-suspension-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Gold down nearly 7% on mine suspension, downgrade</a></h4><ul><li>Due to a lack of sufficient water resources, mill processing operations at the Mount Milligan mine have been temporarily suspended. There should be enough water to restart by the end of January, and full capacity should be reached after April's spring melt.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17034472-royal-gold-receives-operational-update-mount-milligan\" target=\"_blank\">Press Release</a></li><li>\"Confidence in the turnaround has clearly been shaken again,\" says Canaccord, downgrading to Hold from Buy.</li><li><a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a>&nbsp;<font color='red'>-6.7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3320342\" data-linked=\"Royal Gold down nearly 7% on mine suspension, downgrade\" data-tweet=\"$RGLD - Royal Gold down nearly 7% on mine suspension, downgrade https://seekingalpha.com/news/3320342-royal-gold-down-nearly-7-on-mine-suspension-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3320342-royal-gold-down-nearly-7-on-mine-suspension-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320338\" data-ts=\"1514480437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320338-consumers-top-5-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumers - Top 5 Gainers / Losers as of 12:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+28%</font>.LTEA <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320338\" data-linked=\"Consumers - Top 5 Gainers / Losers as of 12:00 PM\" data-tweet=\"$WATT $KBSF $LBCC - Consumers - Top 5 Gainers / Losers as of 12:00 PM https://seekingalpha.com/news/3320338-consumers-top-5-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320338-consumers-top-5-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320337\" data-ts=\"1514479969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUPN\" target=\"_blank\">SUPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320337-b-riley-raises-supernus-pharma-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B. Riley raises its Supernus Pharma price target</a></h4><ul><li>        B. Riley <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171228074135SUPN\" target=\"_blank\">raises</a> its Supernus Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/SUPN' title='Supernus Pharmaceuticals, Inc.'>SUPN</a>) price target from $50 to $54 and reiterates its Buy rating.</li><li>                  The firm cites 2018 tailwinds including sales growth for epilepsy drugs Trokendi XR and Oxtellar XR, development for SPN-810 (for impulsive aggression) and SPN-812 &#40;ADHD&#41;, and development of Oxtellar XR in bipolar disorder.    </li><li>               Firm expects management visibility in January with scheduled presentations and investor meetings.&nbsp;</li><li>               Supernus shares are&nbsp;<font color='green'>up 3.6%</font>&nbsp;to $40.10. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320337\" data-linked=\"B. Riley raises its Supernus Pharma price target\" data-tweet=\"$SUPN - B. Riley raises its Supernus Pharma price target https://seekingalpha.com/news/3320337-b-riley-raises-supernus-pharma-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3320337-b-riley-raises-supernus-pharma-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320336\" data-ts=\"1514478354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320336-cheetah-mobile-appoints-58-com-ceo-to-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile appoints 58.com CEO to board</a></h4><ul><li>        Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) appoints 58.com CEO Michael Jinbo Yao and Matrix Partners founder Michael Lingye Zuo as independent directors effective today.</li><li>               Michael Jinbo Yao will also join the corporate governance and nominating committee while Michael Lingye Zuo will join the audit, compensation, and corporate governance committees. &nbsp;&nbsp;</li><li>               Cheetah Mobile shares are&nbsp;<font color='green'>up 5%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320336\" data-linked=\"Cheetah Mobile appoints 58.com CEO to board\" data-tweet=\"$CMCM - Cheetah Mobile appoints 58.com CEO to board https://seekingalpha.com/news/3320336-cheetah-mobile-appoints-58-com-ceo-to-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3320336-cheetah-mobile-appoints-58-com-ceo-to-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320320\" data-ts=\"1514476801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320320-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color='green'>+17%</font>.<a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='red'>-9%</font>. SKLN <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320320\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$VTVT $DRAD $AMPE - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3320320-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3320320-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320331\" data-ts=\"1514476342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCAP\" target=\"_blank\">GCAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320331-gain-capital-up-10-on-mox-capital-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gain Capital up 10% on Mox Capital boost</a></h4><ul><li>Unlike some \"nonsense\" crypto plays, Gain Capital (NYSE:<a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a>) is set to reap real benefit from Bitcoin, <a href=\"http://moxreports.com/long-gcap/\" target=\"_blank\">says Mox in a</a> new long report.</li><li>The company already launched crypto trading in the U.K. - offering both long and short exposure, and leverage - and is set to roll that out globally within weeks.</li><li>Shares&nbsp;<font color='green'>up 9.75%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3320331\" data-linked=\"Gain Capital up 10% on Mox Capital boost\" data-tweet=\"$GCAP - Gain Capital up 10% on Mox Capital boost https://seekingalpha.com/news/3320331-gain-capital-up-10-on-mox-capital-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3320331-gain-capital-up-10-on-mox-capital-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320325\" data-ts=\"1514474474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WATT\" target=\"_blank\">WATT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320325-energous-competitor-receives-fcc-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energous competitor receives FCC approval</a></h4><ul><li>Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) competitor Powercast <a href=\"http://www.globenewswire.com/news-release/2017/12/26/1274646/0/en/Powercast-to-unveil-FCC-approved-consumer-transmitter-for-power-over-distance-wireless-charging-at-CES-2018.html\" target=\"_blank\">receives FCC approval</a> for its own at-range wireless charging transmitter. The approval came earlier this week alongside Energous' approval.</li><li>The Powercast transmitter can charge up to 80 feet away but only for small, low-power devices.</li><li>The company says power delivery rates improve with proximity. Power-hungry smartwatches and fitness bands should be charged within two feet and keyboard and mice within six feet.</li><li>Energous says its transmitter can recharge multiple devices within three feet. Energous received approval under the FCC&rsquo;s Part 18 rules, which allow for higher-power operations that the Part 15 rule that Powercast was approved under.</li><li>Powercast hopes to have products out in 3Q18 with an initial price of $100.</li><li>Energous shares are&nbsp;<font color='green'>up 25.4%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320307-roth-capital-raises-energous-price-target-fcc-chair-tweets-confirmation\" target=\"_blank\">Roth Capital raises its Energous price target; FCC chair tweets confirmation</a> (Dec. 28)</li><li>Update: Post updated for timeline clarity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320325\" data-linked=\"Energous competitor receives FCC approval\" data-tweet=\"$WATT - Energous competitor receives FCC approval https://seekingalpha.com/news/3320325-energous-competitor-receives-fcc-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3320325-energous-competitor-receives-fcc-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320324\" data-ts=\"1514473879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320324-j-b-hunt-transport-falls-back-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.B. Hunt Transport falls back after guidance update</a></h4><ul> <li>J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='red'>-1.9%</font>) trades lower after posting a guidance <a href=\"https://seekingalpha.com/pr/17034609-j-b-hunt-transport-services-inc-announces-earnings-expectations-fourth-quarter-ended-december\" target=\"_blank\">update</a>.</li> <li>The trucking company expects Q4 revenue of $1.90B to $2.0B vs. $1.91B consensus and Q4 EPS of $0.98 to $1.03 vs. $1.02 consensus. The company also anticipates operating income $145M to $155M for the quarter. Management used an effective tax rate of 37.6% in making the forecast.</li> <li>Although the numbers were solid from J.B. Hunt, shares have already tracked higher over the last month on investor expectations for a strong quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320324\" data-linked=\"J.B. Hunt Transport falls back after guidance update\" data-tweet=\"$JBHT - J.B. Hunt Transport falls back after guidance update https://seekingalpha.com/news/3320324-j-b-hunt-transport-falls-back-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3320324-j-b-hunt-transport-falls-back-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320323\" data-ts=\"1514473704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBC\" target=\"_blank\">AMBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320323-ambac-up-2_5-on-deal-bondholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambac up 2.5% on deal with bondholders</a></h4><ul><li>Ambac (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBC' title='Ambac Financial'>AMBC</a>) has reached agreement with a group of bondholders for the company to purchase from them certain COFINA bonds. After the deal, Ambac will own 58% of its insured COFINA paper.</li><li>Alongside, the bondholder group has withdrawn its objection to the plan to exit the segregated account.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17034756-b-ambac-b-announces-purchase-cofina-bonds-withdrawal-cofina-bondholder-objection-plan\" target=\"_blank\">Press Release</a></li><li>Shares are<font color='green'> higher by 2.5%</font>&nbsp;in early action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320323\" data-linked=\"Ambac up 2.5% on deal with bondholders\" data-tweet=\"$AMBC - Ambac up 2.5% on deal with bondholders https://seekingalpha.com/news/3320323-ambac-up-2_5-on-deal-bondholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3320323-ambac-up-2_5-on-deal-bondholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320322\" data-ts=\"1514473619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WNDW\" target=\"_blank\">WNDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320322-solarwindow-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarWindow on the move</a></h4><ul><li>While the stock has almost doubled since the beginning of the month, SolarWindow Technologies (<a href='https://seekingalpha.com/symbol/WNDW' title='SolarWindow Technologies, Inc.'>OTCPK:WNDW</a>) has tumbled in early trade, now <font color='red'>down 10%</font>.</li><li>Recent posts from Twitter: \"A decade after $WNDW started promoting its stock, it has <a href=\"https://twitter.com/stockgutter/status/943235618603196417\" target=\"_blank\">yet to sell</a> a single 'SolarWindow,'\" as well as \"$WNDW, assets $832k, revenue $0, market cap ~$345MM. This is <a href=\"https://twitter.com/jww1019/status/946056628276785153\" target=\"_blank\">bound to end</a> well, right?\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3320322\" data-linked=\"SolarWindow on the move\" data-tweet=\"$WNDW - SolarWindow on the move https://seekingalpha.com/news/3320322-solarwindow-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3320322-solarwindow-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320316\" data-ts=\"1514471029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ODT\" target=\"_blank\">ODT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320316-odonate-therapeutics-initiates-phase-3-trial-for-tesetaxel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Odonate Therapeutics initiates Phase 3 trial for tesetaxel</a></h4><ul><li>        Odonate Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ODT' title='Odonate Therapeutics, Inc.'>ODT</a>) <a href=\"https://seekingalpha.com/pr/17034704-odonate-therapeutics-announces-initiation-contessa-phase-3-study-tesetaxel-patients-locally\" target=\"_blank\">initiates</a> the Phase 3 CONTESSA trial of tesetaxel in patients with locally advanced or metastatic breast cancer.</li><li>               The trial&rsquo;s primary endpoint is progression-free survival with secondary efficacy endpoints of overall survival, objective response rate, disease control rate, and patient-reported outcomes.</li><li>               Odonate shares are&nbsp;<font color='red'>down&nbsp;1.8%</font>&nbsp;premarket. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320316\" data-linked=\"Odonate Therapeutics initiates Phase 3 trial for tesetaxel\" data-tweet=\"$ODT - Odonate Therapeutics initiates Phase 3 trial for tesetaxel https://seekingalpha.com/news/3320316-odonate-therapeutics-initiates-phase-3-trial-for-tesetaxel?source=tweet\" data-url=\"https://seekingalpha.com/news/3320316-odonate-therapeutics-initiates-phase-3-trial-for-tesetaxel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320315\" data-ts=\"1514470723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320315-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+81%</font>&nbsp;on FY <a href=\"https://seekingalpha.com/news/3320233-live-ventures-reports-fy-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='green'>+36%</font>&nbsp;on 1H <a href=\"https://seekingalpha.com/news/3320299-liniu-technology-reports-1h-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color='green'>+36%</font>&nbsp;on contracts <a href=\"https://seekingalpha.com/news/3320240-digirad-plus-4_6-percent-contracts-sale\" target=\"_blank\">sale</a>.</li>     <li><a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a> <font color='green'>+14%</font>&nbsp;on Amazon <a href=\"https://seekingalpha.com/news/3320310-eros-pops-amazon-inclusion\" target=\"_blank\">inclusion</a>.</li>     <li><a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+12%&nbsp;</font>on <a href=\"https://seekingalpha.com/news/3320307-roth-capital-raises-energous-price-target\" target=\"_blank\">positive</a> analyst action.</li>     <li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320315\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$LIVE $LINU-OLD $DRAD - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3320315-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320315-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320314\" data-ts=\"1514470505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320314-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='red'>-14%</font>.</li><li><a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a>&nbsp;<font color='red'>-9%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3320245-revolution-lighting-minus-3_3-percent-guidance-update\" target=\"_blank\">guidance</a> update.</li><li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>&nbsp;<font color='red'>-9%</font>&nbsp;on Korea <a href=\"https://seekingalpha.com/news/3320264-bitcoin-drops-korea-crypto-crackdown\" target=\"_blank\">crypto</a> crackdown.</li><li><a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3320301-ekso-files-double-common-shares\" target=\"_blank\">increasing</a> the authorized number of shares of the company's common stock.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a>&nbsp;<font color='red'>-8%</font>&nbsp;on&nbsp;India to <a href=\"https://seekingalpha.com/news/3320223-india-breach-fiscal-deficit-target-additional-borrowing\" target=\"_blank\">breach</a> fiscal deficit target after additional borrowing.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>&nbsp;<font color='red'>-7%</font>&nbsp;on Korea&nbsp;<a href=\"https://seekingalpha.com/news/3320264-bitcoin-drops-korea-crypto-crackdown\" target=\"_blank\">crypto</a>&nbsp;crackdown.</li><li><a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>&nbsp;<font color='red'>-6%</font>&nbsp;on Korea&nbsp;<a href=\"https://seekingalpha.com/news/3320264-bitcoin-drops-korea-crypto-crackdown\" target=\"_blank\">crypto</a>&nbsp;crackdown.</li><li><a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3320314\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$TEUM $CLSN $NXTD - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3320314-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320314-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320313\" data-ts=\"1514470409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320313-telsey-sees-macys-tracking-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telsey sees Macy&#39;s tracking higher</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) still looks attractive to Telsey Advisory Group analyst Dana Telsey despite the strong run by the department store since Black Friday.</li> <li>Telsey notes that Macy's only trades at a forward price-to-earnings ratio of 10.2 vs. 17.5 for the sector. A year of relatively easy sales comparables is also on the calendar for Macy's.</li> <li>Macy's is kept at Market Perform by Telsey, but the price target is lifted to $28.</li> <li>Shares of Macy's are<font color='green'> up 0.43%</font> on brisk volume in the premarket session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320313\" data-linked=\"Telsey sees Macy&#39;s tracking higher\" data-tweet=\"$M - Telsey sees Macy&#39;s tracking higher https://seekingalpha.com/news/3320313-telsey-sees-macys-tracking-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3320313-telsey-sees-macys-tracking-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320312\" data-ts=\"1514470182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320312-sonoma-pharmaceuticalsplus-8_9-on-benchmark-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonoma Pharmaceuticals +8.9% on Benchmark initiation</a></h4><ul><li>           The Benchmark Company <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171228084818SNOA\" target=\"_blank\">initiates</a> Sonoma Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a>) with a Speculative Buy rating and a $10 price target. </li><li> The firm predicts Sonoma will reach break-even with cash flow in the December 2019 quarter due to operational improvements including an expanding product mix, declining rebates, and small price increases. </li><li> Benchmark says Sonoma could reach profitability using the $9.9M of cash on hand but might need another $1M to $2M. &nbsp; </li><li> Sonoma shares are&nbsp;<font color='green'>up 8.9%</font>&nbsp;premarket to $5.25.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3320312\" data-linked=\"Sonoma Pharmaceuticals +8.9% on Benchmark initiation\" data-tweet=\"$SNOA - Sonoma Pharmaceuticals +8.9% on Benchmark initiation https://seekingalpha.com/news/3320312-sonoma-pharmaceuticalsplus-8_9-on-benchmark-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3320312-sonoma-pharmaceuticalsplus-8_9-on-benchmark-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320310\" data-ts=\"1514469878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EROS\" target=\"_blank\">EROS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320310-eros-pops-after-amazon-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros pops after Amazon inclusion</a></h4><ul> <li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) soars after announcing that its streaming service is now available to Amazon Prime members for a subscription fee of $7.99.</li>     <li>\"Eros Now's integration with Amazon Channels in       the US and UK further empowers us to reach out to millions of       subscribers and provide them with rich and compelling content, from       movies to music to TV content,\" says Eros Digital CEO Rishika Lulla Singh.</li><li>EROS  <font color='green'>+15.82%</font> premarket to  $11.35. The 52-week high for shares is $16.90.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17034679-eros-now-available-amazon-channels\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3320310\" data-linked=\"Eros pops after Amazon inclusion\" data-tweet=\"$EROS - Eros pops after Amazon inclusion https://seekingalpha.com/news/3320310-eros-pops-after-amazon-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3320310-eros-pops-after-amazon-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320308\" data-ts=\"1514469538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STCC\" target=\"_blank\">STCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320308-blockchain-moonshot-for-microcap-sterling-consolidated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blockchain moonshot for microcap Sterling Consolidated</a></h4><ul>     <li>Sterling Consolidated (<a href='https://seekingalpha.com/symbol/STCC' title='Sterling Consolidated Corp'>OTCQB:STCC</a>) announces plans for a decentralized international marketplace for O-rings called DiMo.</li>     <li>\"We believe that, based on its highly fragmented structure with thousands of distributors and very few suppliers in Asia, the O-ring industry lends itself perfectly to utilization of the Blockchain and smart contract technology,\" says Sterling CEO&nbsp;Darren DeRosa.</li>     <li>Sterling has partnered with BlockchainDriven in its crypto efforts.</li>     <li>STCC closed up&nbsp;<font color='green'>179.%</font>&nbsp;to $0.1397 yesterday before the announcement hit. Today's action could be interesting to say the least.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17034491-sterling-consolidated-rolls-strategic-plan-utilize-blockchain-technology-build-dimo-first\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3320308\" data-linked=\"Blockchain moonshot for microcap Sterling Consolidated\" data-tweet=\"$STCC - Blockchain moonshot for microcap Sterling Consolidated https://seekingalpha.com/news/3320308-blockchain-moonshot-for-microcap-sterling-consolidated?source=tweet\" data-url=\"https://seekingalpha.com/news/3320308-blockchain-moonshot-for-microcap-sterling-consolidated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320307\" data-ts=\"1514469381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WATT\" target=\"_blank\">WATT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320307-roth-capital-raises-energous-price-target-fcc-chair-tweets-confirmation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roth Capital raises its Energous price target; FCC chair tweets confirmation</a></h4><ul><li>Roth Capital <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiO1Z7Y7KzYAhXTqYMKHcgoCmIQFggnMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FUPDATE%3A%2BEnergous%2BCorp%2B%28WATT%29%2BPT%2BRaised%2Bto%2B%2445.80%2Bat%2BRoth%2BCapital%2C%2BStreet%2BHigh%2C%2BFCC%2BCertifies%2BMid%2BField%2BTransmitter%2F13634583.html&amp;usg=AOvVaw3_ANiJM4DzzHdND5htRufr\" target=\"_blank\">raises</a> its Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) price target from $22.80 to $45.80 and maintains a Buy rating.</li><li>Energous share are&nbsp;<font color='green'>up 8.6%</font>&nbsp;premarket to $25.74. Shares are&nbsp;<font color='green'>up 156%</font>&nbsp;this week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320128-energous-skies-89-percent-winning-fcc-certification\" target=\"_blank\">Energous skies 89% after winning FCC certification</a> (Dec. 27)</li><li>        Update with analyst comments: Roth analyst William Gibson cites the FCC certification as setting the stage for new WattUp tech with more power, functionality, and scale.</li><li>               Gibson notes that the first products are expected to launch in Q1, and he expects the FCC approval process to speed up over time.&nbsp;</li><li>                  The analyst says Energous needs more money with only $20.2M in cash as of Q3. Funds could arrive through strategic partnerships such as Dialog exercising its warrants.    </li><li>               Source: Bloomberg First Word.&nbsp;</li><li><strong>FCC confirmation:</strong>&nbsp;FCC Chairman Ajit Pai <a href=\"https://twitter.com/AjitPaiFCC/status/946051258753912832\" target=\"_blank\">tweets</a> about the approval with a link to Energous&rsquo; announcement press release.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320307\" data-linked=\"Roth Capital raises its Energous price target; FCC chair tweets confirmation\" data-tweet=\"$WATT - Roth Capital raises its Energous price target; FCC chair tweets confirmation https://seekingalpha.com/news/3320307-roth-capital-raises-energous-price-target-fcc-chair-tweets-confirmation?source=tweet\" data-url=\"https://seekingalpha.com/news/3320307-roth-capital-raises-energous-price-target-fcc-chair-tweets-confirmation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320301\" data-ts=\"1514467849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320301-ekso-files-to-double-common-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso files to double common shares</a></h4><ul><li>Ekso Bionics (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) <a href=\"https://www.streetinsider.com/Corporate+News/Ekso+Bionics+%28EKSO%29+Files+to+Nearly+Double+Authorized+Common+Shares/13633916.html\" target=\"_blank\">disclosed</a> that it filed to increase the authorized number of shares of the company's common stock from 71,428,571 shares to 141,428,571 shares on Dec. 22.</li><li>The charter amendment was approved by the company&rsquo;s stockholders at a Special Meeting of Stockholders held on Dec. 21.</li><li>EKSO <font color='red'>-11.3%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3320301\" data-linked=\"Ekso files to double common shares\" data-tweet=\"$EKSO - Ekso files to double common shares https://seekingalpha.com/news/3320301-ekso-files-to-double-common-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3320301-ekso-files-to-double-common-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320296\" data-ts=\"1514466738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320296-intercept-pharmaceuticals-shifts-announcement-of-nash-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharmaceuticals shifts announcement of NASH trial</a></h4><ul><li>        Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) <a href=\"https://seekingalpha.com/filing/3811525\" target=\"_blank\">shifts its guidance</a> for announcing the Phase 3 REVERSE trial in NASH patients with compensated cirrhosis.</li><li>               The announcement will now come in 1Q18 rather than at the end of 2017.&nbsp;</li><li>               Intercept shares are&nbsp;<font color='green'>up 4.5%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320296\" data-linked=\"Intercept Pharmaceuticals shifts announcement of NASH trial\" data-tweet=\"$ICPT - Intercept Pharmaceuticals shifts announcement of NASH trial https://seekingalpha.com/news/3320296-intercept-pharmaceuticals-shifts-announcement-of-nash-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3320296-intercept-pharmaceuticals-shifts-announcement-of-nash-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":30,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}